Melatonin Eql Pharma

Melatonin, the active ingredient in Melatonin Eql Pharma, is a sleep aid presented as an oral dosage form for oral use. It helps regulate the circadian rhythm and supports sleep onset in adults with insomnia, jet lag or other circadian rhythm sleep disorders.

GNH USA supplies Melatonin Eql Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin Eql Pharma is used to address disorders of the sleep‑wake cycle.

Insomnia: promotes faster sleep onset and improves sleep continuity. Jet lag: assists adjustment to new time zones by normalising the internal clock. Circadian rhythm sleep disorders: supports alignment of the body’s circadian rhythm with the desired schedule.

Adverse reactions reported with melatonin are generally mild and dose‑dependent.

Common Side Effects: - Drowsiness - Headache - Dizziness - Nausea - Vivid dreams - Abdominal discomfort

Serious or Rare Side Effects: - Allergic reactions such as rash, itching or swelling - Severe dizziness or fainting - Mood changes including depression or irritability - Hallucinations or confusion (rare) - Respiratory depression (extremely rare)

When considering melatonin therapy, several precautions should be observed.

Assess underlying sleep disorder: confirm diagnosis before initiating therapy. Avoid operating machinery: potential residual drowsiness may impair alertness. Use caution in hepatic impairment: metabolism may be reduced. Not recommended for children without pediatric supervision: safety data are limited. Monitor concurrent sedatives: risk of additive CNS depression. Store at below 25°C: keep in the original packaging, protect from moisture and light.

Melatonin may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Central nervous system depressants (e.g., benzodiazepines, barbiturates): may cause excessive sedation. - Anticoagulants (e.g., warfarin): melatonin can increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may alter melatonin metabolism.

Moderate Interactions (Monitor Closely): - Oral contraceptives: can raise melatonin plasma levels. - Selective serotonin reuptake inhibitors: may affect sleep architecture. - Caffeine‑containing products: may reduce melatonin’s efficacy. - Antihypertensive agents: occasional reports of altered blood pressure control.